SurModics
SRDX
$33.33
Share price
29.74%
Change (1 day)
44.98%
Change (1 year)
Categories
Operating Margin for SurModics (SRDX)
Operating Margin as of May 2024 (TTM): -22.50%
According to SurModics's latest financial reports and stock price the company's current Operating Margin is -22.50%. At the end of 2022 the company had an Operating Margin of -22.50%.
Operating Margin history for SurModics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -22.50% | -472.83% |
| 2021 | 6.04% | -493.81% |
| 2020 | -1.53% | -120.3% |
| 2019 | 7.55% | -181.55% |
| 2018 | -9.26% | -196.27% |
| 2017 | 9.62% | -59.49% |
| 2016 | 23.75% | -19.41% |
| 2015 | 29.47% | -8.36% |
| 2014 | 32.16% | -11.34% |
| 2013 | 36.27% | 15.51% |
| 2012 | 31.40% | -229.06% |
| 2011 | -24.33% | -17.68% |
| 2010 | -29.56% | -160.35% |
| 2009 | 48.98% | 76.75% |
| 2008 | 27.71% | 38.21% |
| 2007 | 20.05% | -60.61% |
| 2006 | 50.89% | 629.81% |
| 2005 | 6.97% | -70.72% |
| 2004 | 23.82% | -54.24% |
| 2003 | 52.04% | 23.79% |
| 2002 | 42.04% | -10.17% |
| 2001 | 46.80% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -201.69% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -169.33% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 14.17% | -162.98% | 🇺🇸 USA |
 Agilent Technologies A | 23.28% | -203.47% | 🇺🇸 USA |
 PerkinElmer
PKI | 14.13% | -162.80% | 🇺🇸 USA |
 Alkermes ALKS | -15.04% | -33.16% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | -396.48% | 1,662.13% | 🇺🇸 USA |
 Heron Therapeutics HRTX | -169.05% | 651.33% | 🇺🇸 USA |
 Enzo Biochem ENZ | -43.44% | 93.07% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.